Faculty, Staff and Student Publications

Language

English

Publication Date

10-1-2025

Journal

Annals of Surgical Oncology

DOI

10.1245/s10434-025-17787-8

PMID

40659896

PMCID

PMC12454588

PubMedCentral® Posted Date

7-14-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Background: Perivascular epithelioid cell tumors (PEComa) are a rare family of mesenchymal tumors that include several subtypes. There are very limited data describing the natural history of patients with extra-visceral retroperitoneal PEComas of the retroperitoneum. The aim of this study is to describe the clinical features, treatment patterns, outcomes, and diagnostic challenges of primary extra-visceral retroperitoneal or abdominopelvic PEComa over the past decade.

Patients and methods: This is a retrospective analysis of all extra-visceral, non-renal, retroperitoneal, or abdominopelvic PEComas treated at participating centers over the past 10 years.

Results: A total of 77 patients from 13 centers were included. The median age at diagnosis was 56 years (range 18-81 years); 73% were female. The median size was 9 cm. The tumor was classified as a PEComa not otherwise specified (NOS) in 55 (71%), sclerosing PEComa in 11 (15%), and angiomyolipoma (AML) in 11 (15%). Treatment intent was curative in 59 (77%) patients. Adjuvant radiation was given in five (8%) patients, and (neo)adjuvant systemic therapy was given to six (10%). Of those who did not undergo curative intent treatment, four (22%) patients had metastatic disease and three (17%) had primary unresectable disease. With a median follow-up of 26 months (2.3-147 months), 24 (40%) of the 59 patients having curative treatment had recurred. Recurrence rates differed by subtype, with 20 (37%) of the PEComa NOS group, 3 (27%) of the sclerosing PEComa group, and 1 (9%) of the AML group developing recurrence. The estimated 5-year OS of the whole cohort was 63% and 75% for the curative intent group.

Conclusions: Retroperitoneal and abdominopelvic PEComas show distinct behaviors by subtype. PEComa NOS had the highest recurrence and mortality, sclerosing PEComa showed intermediate risk, and AML was indolent. Histological classification is essential for prognosis and management.

Keywords

Humans, Female, Middle Aged, Adult, Retroperitoneal Neoplasms, Aged, Perivascular Epithelioid Cell Neoplasms, Aged, 80 and over, Retrospective Studies, Male, Adolescent, Young Adult, Prognosis, Follow-Up Studies, Survival Rate, Neoplasm Recurrence, Local, Sarcoma, PEComa, Retroperitoneal sarcoma, Surgical oncology, Perivascular epithelioid cell tumors

Comments

This article has been corrected. See Ann Surg Oncol. 2025 Jul 29;32(10):7843.

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.